Evidence map›Paper›PMID 39313645›Full record

ArticleNature biotechnology2025

Scalable and unsupervised discovery from raw sequencing reads using SPLASH2.

Marek Kokot, Roozbeh Dehghannasiri, Tavor Baharav, Julia Salzman, Sebastian Deorowicz

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pretraining and the lasso.Journal of the Royal Statistical Society. Series B, Statistical methodology · 2026
    Article
  6. Article
  7. Article
  8. OASIS: An interpretable, finite-sample valid alternative to Pearson'sbioRxiv : the preprint server for biology · 2023
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Marek Kokot *Department of Algorithmics and Software, Silesian University of Technology, Gliwice, Poland.ORCID http://orcid.org/0000-0002-6420-1587
Roozbeh Dehghannasiri *Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-7413-3437
Tavor BaharavDepartment of Electrical Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-8924-0243
Julia SalzmanDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA. julia.salzman@stanford.edu.ORCID http://orcid.org/0000-0001-7630-3436
Sebastian DeorowiczDepartment of Algorithmics and Software, Silesian University of Technology, Gliwice, Poland. sebastian.deorowicz@polsl.pl.ORCID http://orcid.org/0000-0002-9496-733X

Funding

Computational- and experimental- driven discovery of splicing regulation and circRNA functionR35GM139517 · NIGMS · STANFORD UNIVERSITY · PI Julia Salzman · 2021 to 2026
$2.9M
Narodowe Centrum Nauki (National Science Centre) DEC-2022/45/B/ST6/03032NIGMS NIH HHS R35 GM139517
6 · The paper itself

Abstract

We introduce SPLASH2, a fast, scalable implementation of SPLASH based on an efficient k-mer counting approach for regulated sequence variation detection in massive datasets from a wide range of sequencing technologies and biological contexts. We demonstrate biological discovery by SPLASH2 in single-cell RNA sequencing (RNA-seq) data and in bulk RNA-seq data from the Cancer Cell Line Encyclopedia, including unannotated alternative splicing in cancer transcriptomes and sensitive detection of circular RNA.

Indexed as

High-Throughput Nucleotide SequencingSequence Analysis, RNASoftwareAlgorithmsAlternative SplicingCell Line, TumorHumansNeoplasmsSingle-Cell AnalysisTranscriptome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.